Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.26383 | 85 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.33805 | 84 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.33981 | 85 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.73442 | 86 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.07866 | 83 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.14779 | 85 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.46553 | 87 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.65566 | 87 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.35228 | 85 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.31616 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.22792 | 84 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.4769 | 85 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.30408 | 85 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.32972 | 85 |